Related Experiment Video
Updated: May 3, 2026
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
The genomic landscape of retinoblastoma: a review
Brigitte L Thériault1, Helen Dimaras, Brenda L Gallie
1Campbell Family Cancer Research Institute, Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Abstract:
Retinoblastoma is a paediatric ocular tumour that continues to reveal much about the genetic basis of cancer development. Study of genomic aberrations in retinoblastoma tumours has exposed important mechanisms of cancer development and identified oncogenes and tumour suppressors that offer potential points of therapeutic intervention. The recent development of next-generation genomic technologies has allowed further refinement of the genomic landscape of retinoblastoma at high resolution. In a relatively short period of time, a wealth of genetic and epigenetic data has emerged on a small number of tumour samples. These data highlight the inherent molecular complexity of this cancer despite the fact that most retinoblastomas are initiated by the inactivation of a single tumour suppressor gene. This review outlines the current understanding of the genomic, genetic and epigenetic changes in retinoblastoma, highlighting recent genome-wide analyses that have identified exciting candidate genes worthy of further validation as potential prognostic and therapeutic targets.
Insights
Retinoblastoma, a childhood eye cancer, offers insights into cancer genetics. Genomic and epigenetic studies reveal its complexity and identify potential therapeutic targets for improved treatment.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Retinoblastoma is a significant pediatric ocular tumor.
- Its study provides crucial insights into the genetic basis of cancer development.
- Genomic aberrations in retinoblastoma have elucidated key cancer mechanisms.
Purpose of the Study:
- To review the current understanding of genomic, genetic, and epigenetic changes in retinoblastoma.
- To highlight recent genome-wide analyses and their findings.
- To identify potential prognostic and therapeutic targets.
Main Methods:
- Review of existing literature on retinoblastoma genomics, genetics, and epigenetics.
- Analysis of recent genome-wide studies utilizing next-generation sequencing technologies.
- Synthesis of data from a small number of tumor samples.
Main Results:
- Retinoblastoma exhibits molecular complexity despite initial single-gene inactivation.
- Next-generation genomic technologies have refined the understanding of its genomic landscape.
- Numerous candidate genes for prognostic and therapeutic intervention have been identified.
Conclusions:
- Understanding retinoblastoma's genetic and epigenetic alterations is crucial for targeted therapies.
- Further validation of identified candidate genes is necessary.
- Advances in genomic technologies continue to deepen insights into this pediatric cancer.
More Related Videos
Related Concept Videos
01:20The Retinoblastoma Gene
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:03Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...